Vault-13

Soleus Capital Management, L.P.

GREENWICH, CT · CIK 1802630 · 13F filing filed 2026-08-11

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$2.9bn reported value +17.5% vs Q1 2026
97positions
48.9%in top 10
22 new 25 added 41 reduced 18 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 KRYSTAL BIOTECH INC COM KRYS KRYS 939,254 $349.1m12.03% 12.03% ReducedShares held: Q3 2025 1.0m, Q4 2025 941.1k, Q1 2026 1.2m, Q2 2026 939.3k -213.8k -213,833 -18.5%
2 CELCUITY INC COM CELC CELC 1,704,318 $178.3m6.14% 6.14% AddedShares held: Q3 2025 1.2m, Q4 2025 1.8m, Q1 2026 1.3m, Q2 2026 1.7m +419.9k +419,940 32.7%
3 TG THERAPEUTICS INC COM TGTX TGTX 2,927,895 $160.9m5.54% 5.54% ReducedShares held: Q3 2025 3.8m, Q4 2025 3.1m, Q1 2026 4.0m, Q2 2026 2.9m -1.1m -1,101,424 -27.3%
4 INSULET CORP COM PODD PODD 1,049,000 $159.7m5.50% 5.50% AddedShares held: Q3 2025 0, Q4 2025 150.0k, Q1 2026 562.5k, Q2 2026 1.0m +486.5k +486,500 86.5%
5 NOVOCURE LTD ORD SHS NVCR NVCR 9,913,401 $150.2m5.18% 5.18% ReducedShares held: Q3 2025 9.6m, Q4 2025 8.5m, Q1 2026 10.5m, Q2 2026 9.9m -579.0k -578,990 -5.5%
6 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 225,587 $122.2m4.21% 4.21% AddedShares held: Q3 2025 150.0k, Q4 2025 60.0k, Q1 2026 187.2k, Q2 2026 225.6k +38.4k +38,400 20.5%
7 INSPIRE MED SYS INC COM INSP INSP 1,931,436 $86.2m2.97% 2.97% AddedShares held: Q3 2025 728.2k, Q4 2025 299.4k, Q1 2026 576.3k, Q2 2026 1.9m +1.4m +1,355,137 235.1%
8 RIGEL PHARMACEUTICALS INC COM RIGL RIGL 1,843,504 $72.1m2.49% 2.49% AddedShares held: Q3 2025 330.0k, Q4 2025 300.0k, Q1 2026 10.0k, Q2 2026 1.8m +1.8m +1,833,504 18335.0%
9 ANI PHARMACEUTICALS INC COM ANIP ANIP 867,760 $71.8m2.48% 2.48% AddedShares held: Q3 2025 340.2k, Q4 2025 486.2k, Q1 2026 820.2k, Q2 2026 867.8k +47.5k +47,517 5.8%
10 BETA BIONICS INC COM BBNX BBNX 4,393,714 $68.8m2.37% 2.37% AddedShares held: Q3 2025 3.9m, Q4 2025 2.5m, Q1 2026 4.4m, Q2 2026 4.4m +39.2k +39,213 0.9%
11 VERICEL CORP COM VCEL VCEL 1,459,152 $64.9m2.24% 2.24% ReducedShares held: Q3 2025 498.0k, Q4 2025 764.0k, Q1 2026 2.5m, Q2 2026 1.5m -1.1m -1,089,927 -42.8%
12 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 177,517 $59.4m2.05% 2.05% ReducedShares held: Q3 2025 859.2k, Q4 2025 363.0k, Q1 2026 330.5k, Q2 2026 177.5k -153.0k -153,000 -46.3%
13 GERON CORP COM GERN GERN 42,808,659 $54.8m1.89% 1.89% AddedShares held: Q3 2025 17.3m, Q4 2025 23.3m, Q1 2026 41.5m, Q2 2026 42.8m +1.3m +1,300,000 3.1%
14 ALKERMES PLC SHS ALKS ALKS 1,029,252 $53.9m1.86% 1.86% ReducedShares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 2.0m, Q2 2026 1.0m -941.6k -941,612 -47.8%
15 ERASCA INC COM ERAS ERAS 2,700,000 $49.5m1.70% 1.70% NewShares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 0, Q2 2026 2.7m
16 NEUROPACE INC COM NPCE NPCE 2,911,122 $46.3m1.59% 1.59% ReducedShares held: Q3 2025 3.0m, Q4 2025 2.7m, Q1 2026 2.9m, Q2 2026 2.9m -21.1k -21,085 -0.7%
17 PROGYNY INC COM PGNY PGNY 1,602,000 $46.2m1.59% 1.59% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.1m, Q2 2026 1.6m -465.0k -465,000 -22.5%
18 INDIVIOR PHARMACEUTICALS INC COM INDV INDV 1,064,000 $43.7m1.50% 1.50% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.3m, Q2 2026 1.1m -210.0k -210,000 -16.5%
19 PARABILIS MEDICINES INC COM PBLS PBLS 1,465,070 $40.1m1.38% 1.38% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.5m
20 EDAP TMS S A SPONSORED ADR FOCL FOCL 7,309,254 $37.9m1.30% 1.30% UnchangedShares held: Q3 2025 7.3m, Q4 2025 7.3m, Q1 2026 7.3m, Q2 2026 7.3m
21 GLOBUS MED INC CL A GMED GMED 468,922 $37.0m1.28% 1.28% ReducedShares held: Q3 2025 176.0k, Q4 2025 887.0k, Q1 2026 729.5k, Q2 2026 468.9k -260.5k -260,545 -35.7%
22 ARCUS BIOSCIENCES INC COM RCUS RCUS 1,168,738 $36.0m1.24% 1.24% AddedShares held: Q3 2025 0, Q4 2025 712.0k, Q1 2026 452.0k, Q2 2026 1.2m +716.8k +716,755 158.6%
23 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,628,039 $35.6m1.23% 1.23% ReducedShares held: Q3 2025 2.0m, Q4 2025 2.2m, Q1 2026 1.7m, Q2 2026 1.6m -98.9k -98,869 -5.7%
24 NURIX THERAPEUTICS INC COM NRIX NRIX 1,465,163 $35.5m1.22% 1.22% AddedShares held: Q3 2025 2.4m, Q4 2025 1.2m, Q1 2026 938.2k, Q2 2026 1.5m +527.0k +527,000 56.2%
25 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 1,205,000 $34.8m1.20% 1.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
26 JADE BIOSCIENCES INC COM NEW JBIO JBIO 1,550,690 $34.5m1.19% 1.19% AddedShares held: Q3 2025 796.7k, Q4 2025 796.7k, Q1 2026 796.7k, Q2 2026 1.6m +753.9k +753,946 94.6%
27 UNITEDHEALTH GROUP INC COM UNH UNH 80,000 $33.3m1.15% 1.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.0k
28 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 1,654,978 $30.6m1.05% 1.05% AddedShares held: Q3 2025 0, Q4 2025 442.0k, Q1 2026 442.0k, Q2 2026 1.7m +1.2m +1,213,000 274.4%
29 UROGEN PHARMA LTD COM URGN URGN 829,810 $30.5m1.05% 1.05% AddedShares held: Q3 2025 679.0k, Q4 2025 150.0k, Q1 2026 727.0k, Q2 2026 829.8k +102.8k +102,810 14.1%
30 MBX BIOSCIENCES INC COM MBX MBX 515,279 $28.4m0.98% 0.98% AddedShares held: Q3 2025 275.0k, Q4 2025 408.9k, Q1 2026 178.9k, Q2 2026 515.3k +336.4k +336,382 188.0%
31 PALISADE BIO INC COM PALI PALI 13,063,687 $27.3m0.94% 0.94% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.1m
32 PHARVARIS N V COM PHVS PHVS 730,907 $25.3m0.87% 0.87% AddedShares held: Q3 2025 647.1k, Q4 2025 702.1k, Q1 2026 702.1k, Q2 2026 730.9k +28.9k +28,855 4.1%
33 ORGANOGENESIS HLDGS INC COM ORGO ORGO 10,140,951 $24.6m0.85% 0.85% AddedShares held: Q3 2025 12.1m, Q4 2025 10.0m, Q1 2026 10.1m, Q2 2026 10.1m +55.0k +55,000 0.6%
34 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 520,000 $24.2m0.83% 0.83% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 520.0k
35 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 1,003,000 $22.6m0.78% 0.78% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 160.0k, Q2 2026 1.0m +843.0k +843,000 526.9%
36 TANGO THERAPEUTICS INC COM TNGX TNGX 709,000 $22.2m0.76% 0.76% AddedShares held: Q3 2025 300.0k, Q4 2025 10.0k, Q1 2026 450.0k, Q2 2026 709.0k +259.0k +259,000 57.6%
37 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 10,875,000 $22.1m0.76% 0.76% UnchangedShares held: Q3 2025 6.3m, Q4 2025 10.9m, Q1 2026 10.9m, Q2 2026 10.9m
38 TREVI THERAPEUTICS INC COM TRVI TRVI 1,179,618 $22.0m0.76% 0.76% ReducedShares held: Q3 2025 25.0k, Q4 2025 900.0k, Q1 2026 1.6m, Q2 2026 1.2m -440.4k -440,382 -27.2%
39 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 375,572 $21.5m0.74% 0.74% ReducedShares held: Q3 2025 890.3k, Q4 2025 1.3m, Q1 2026 650.6k, Q2 2026 375.6k -275.0k -275,000 -42.3%
40 LIVANOVA PLC SHS LIVN LIVN 254,957 $21.0m0.72% 0.72% ReducedShares held: Q3 2025 0, Q4 2025 567.5k, Q1 2026 582.5k, Q2 2026 255.0k -327.5k -327,543 -56.2%
41 ARGENX SE SPONSORED ADR ARGX ARGX 19,955 $18.5m0.64% 0.64% AddedShares held: Q3 2025 69.4k, Q4 2025 31.7k, Q1 2026 3.5k, Q2 2026 20.0k +16.5k +16,455 470.1%
42 NUVECTIS PHARMA INC COM NVCT NVCT 1,000,000 $18.4m0.63% 0.63% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
43 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 761,737 $18.3m0.63% 0.63% NewShares held: Q3 2025 0, Q4 2025 646.4k, Q1 2026 0, Q2 2026 761.7k
44 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 450,889 $18.3m0.63% 0.63% ReducedShares held: Q3 2025 0, Q4 2025 910.0k, Q1 2026 1.4m, Q2 2026 450.9k -999.0k -999,026 -68.9%
45 PRELUDE THERAPEUTICS INC COM PRLD PRLD 3,378,378 $18.0m0.62% 0.62% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.4m
46 XENON PHARMACEUTICALS INC COM XENE XENE 267,000 $16.1m0.56% 0.56% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 292.0k, Q2 2026 267.0k -25.0k -25,000 -8.6%
47 C4 THERAPEUTICS INC COM STK CCCC CCCC 3,377,981 $15.8m0.54% 0.54% ReducedShares held: Q3 2025 7.1m, Q4 2025 3.8m, Q1 2026 3.8m, Q2 2026 3.4m -426.0k -425,961 -11.2%
48 KINIKSA PHARMACEUTICALS INTL ORD SHS CL A KNSA KNSA 246,353 $15.8m0.54% 0.54% ReducedShares held: Q3 2025 150.0k, Q4 2025 587.0k, Q1 2026 521.4k, Q2 2026 246.4k -275.0k -275,000 -52.8%
49 ORTHOPEDIATRICS CORP COM KIDS KIDS 732,144 $14.0m0.48% 0.48% AddedShares held: Q3 2025 128.0k, Q4 2025 525.4k, Q1 2026 615.4k, Q2 2026 732.1k +116.7k +116,697 19.0%
50 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 419,000 $13.8m0.48% 0.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 419.0k
51 BIODESIX INC COM BDSX BDSX 585,958 $13.2m0.46% 0.46% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 416.6k, Q2 2026 586.0k +169.4k +169,359 40.6%
52 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 147,000 $13.1m0.45% 0.45% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 147.0k
53 TWIST BIOSCIENCE CORP COM TWST TWST 104,629 $10.8m0.37% 0.37% ReducedShares held: Q3 2025 1.9m, Q4 2025 1.9m, Q1 2026 1.2m, Q2 2026 104.6k -1.1m -1,122,000 -91.5%
54 VIR BIOTECHNOLOGY INC COM VIR VIR 1,000,000 $10.2m0.35% 0.35% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 1.0m -1.0m -1,002,000 -50.0%
55 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 33,050 $9.9m0.34% 0.34% ReducedShares held: Q3 2025 15.2k, Q4 2025 70.0k, Q1 2026 131.7k, Q2 2026 33.0k -98.6k -98,600 -74.9%
56 IMMUNOVANT INC COM IMVT IMVT 252,000 $9.7m0.33% 0.33% AddedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 230.0k, Q2 2026 252.0k +22.0k +22,000 9.6%
57 INSMED INC COM PAR $.01 INSM INSM 90,250 $9.6m0.33% 0.33% AddedShares held: Q3 2025 2.5k, Q4 2025 48.5k, Q1 2026 10.2k, Q2 2026 90.2k +80.0k +80,000 780.5%
58 SEPTERNA INC COM SEPN SEPN 275,000 $9.2m0.32% 0.32% UnchangedShares held: Q3 2025 18.3k, Q4 2025 383.4k, Q1 2026 275.0k, Q2 2026 275.0k
59 SOPHIA GENETICS SA ORDINARY SHARES SOPH SOPH 1,565,000 $9.0m0.31% 0.31% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.9m, Q2 2026 1.6m -285.0k -285,000 -15.4%
60 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 128,362 $9.0m0.31% 0.31% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 128.4k
61 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 75,000 $8.8m0.30% 0.30% ReducedShares held: Q3 2025 148.7k, Q4 2025 573.6k, Q1 2026 400.3k, Q2 2026 75.0k -325.3k -325,306 -81.3%
62 ARTIVION INC COM AORT AORT 388,000 $8.7m0.30% 0.30% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 388.0k
63 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 575,000 $8.7m0.30% 0.30% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 783.0k, Q2 2026 575.0k -208.0k -208,000 -26.6%
64 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 165,677 $8.4m0.29% 0.29% ReducedShares held: Q3 2025 0, Q4 2025 1.0m, Q1 2026 230.9k, Q2 2026 165.7k -65.2k -65,192 -28.2%
65 SIONNA THERAPEUTICS INC COM SION SION 177,687 $7.8m0.27% 0.27% ReducedShares held: Q3 2025 413.5k, Q4 2025 268.5k, Q1 2026 293.5k, Q2 2026 177.7k -115.8k -115,813 -39.5%
66 BELITE BIO INC SPONSORED ADS BLTE BLTE 50,524 $7.8m0.27% 0.27% NewShares held: Q3 2025 210.0k, Q4 2025 40.4k, Q1 2026 0, Q2 2026 50.5k
67 CERUS CORP COM CERS CERS 2,500,000 $7.3m0.25% 0.25% ReducedShares held: Q3 2025 0, Q4 2025 4.0m, Q1 2026 10.8m, Q2 2026 2.5m -8.3m -8,253,700 -76.8%
68 SILENCE THERAPEUTICS PLC ADS SLN SLN 630,000 $6.9m0.24% 0.24% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 630.0k
69 IMMUNIC INC COM NEW IMUX IMUX 450,000 $6.9m0.24% 0.24% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 450.0k
70 INVIVYD INC COM IVVD IVVD 7,708,727 $6.7m0.23% 0.23% UnchangedShares held: Q3 2025 0, Q4 2025 7.7m, Q1 2026 7.7m, Q2 2026 7.7m
71 MERCK & CO INC COM MRK MRK 50,000 $6.4m0.22% 0.22% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 203.0k, Q2 2026 50.0k -153.0k -153,000 -75.4%
72 RELMADA THERAPEUTICS INC COM RLMD RLMD 842,106 $5.8m0.20% 0.20% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 842.1k, Q2 2026 842.1k
73 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 107,000 $5.7m0.20% 0.20% AddedShares held: Q3 2025 0, Q4 2025 90.0k, Q1 2026 80.0k, Q2 2026 107.0k +27.0k +27,000 33.8%
74 EVOLUS INC COM EOLS EOLS 822,428 $5.7m0.20% 0.20% ReducedShares held: Q3 2025 1.4m, Q4 2025 1.1m, Q1 2026 2.2m, Q2 2026 822.4k -1.4m -1,422,932 -63.4%
75 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 405,523 $4.7m0.16% 0.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 405.5k
76 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 950,000 $4.6m0.16% 0.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 950.0k
77 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 440,000 $4.3m0.15% 0.15% UnchangedShares held: Q3 2025 0, Q4 2025 440.0k, Q1 2026 440.0k, Q2 2026 440.0k
78 CONTEXT THERAPEUTICS INC COM CNTX CNTX 7,063,141 $3.9m0.13% 0.13% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 7.0m, Q2 2026 7.1m +100.0k +100,000 1.4%
79 PULMONX CORP COM LUNG LUNG 2,788,323 $3.6m0.12% 0.12% UnchangedShares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 2.8m, Q2 2026 2.8m
80 SAB BIOTHERAPEUTICS INC COM NEW SABS SABS 900,000 $3.5m0.12% 0.12% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 900.0k -150.0k -150,000 -14.3%
81 TECTONIC THERAPEUTIC INC COM TECX TECX 101,684 $3.5m0.12% 0.12% ReducedShares held: Q3 2025 25.0k, Q4 2025 0, Q1 2026 121.7k, Q2 2026 101.7k -20.0k -20,000 -16.4%
82 AXOGEN INC COM AXGN AXGN 57,036 $2.6m0.09% 0.09% ReducedShares held: Q3 2025 1.7m, Q4 2025 1.2m, Q1 2026 679.2k, Q2 2026 57.0k -622.1k -622,134 -91.6%
83 SATELLOS BIOSCIENCE INC COM MSLE MSLE 314,359 $2.4m0.08% 0.08% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 414.4k, Q2 2026 314.4k -100.0k -100,000 -24.1%
84 ARRIVENT BIOPHARMA INC COM AVBP AVBP 50,000 $1.7m0.06% 0.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 50.0k
85 CORCEPT THERAPEUTICS INC COM CORT CORT 19,653 $1.7m0.06% 0.06% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 285.5k, Q2 2026 19.7k -265.9k -265,878 -93.1%
86 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 150,000 $1.5m0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k
87 VERACYTE INC COM VCYT VCYT 25,000 $1.5m0.05% 0.05% ReducedShares held: Q3 2025 422.1k, Q4 2025 10.0k, Q1 2026 319.9k, Q2 2026 25.0k -294.9k -294,912 -92.2%
88 CULLINAN THERAPEUTICS INC COM CGEM CGEM 50,000 $910.5k0.03% 0.03% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 410.2k, Q2 2026 50.0k -360.2k -360,200 -87.8%
89 INSPIREMD INC COM NSPR NSPR 1,045,708 $732.1k0.03% 0.03% UnchangedShares held: Q3 2025 1.5m, Q4 2025 1.1m, Q1 2026 1.0m, Q2 2026 1.0m
90 GENEDX HOLDINGS CORP COM CL A WGS WGS 10,000 $686.5k0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.0k
91 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 150,000 $624.0k0.02% 0.02% ReducedShares held: Q3 2025 976.7k, Q4 2025 0, Q1 2026 1.0m, Q2 2026 150.0k -850.0k -850,000 -85.0%
92 LARIMAR THERAPEUTICS INC COM LRMR LRMR 188,102 $573.7k0.02% 0.02% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 188.1k -878.9k -878,858 -82.4%
93 CG ONCOLOGY INC COM CGON CGON 5,000 $355.2k0.01% 0.01% ReducedShares held: Q3 2025 290.0k, Q4 2025 170.0k, Q1 2026 20.0k, Q2 2026 5.0k -15.0k -15,000 -75.0%
94 QUOIN PHARMACEUTICALS LTD SPONSORED ADS QNRX QNRX 72,730 $352.0k0.01% 0.01% UnchangedShares held: Q3 2025 0, Q4 2025 25.0k, Q1 2026 72.7k, Q2 2026 72.7k
95 EQUILLIUM INC COM EQ EQ 90,000 $288.0k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 90.0k
96 NATERA INC COM NTRA NTRA 1,000 $271.4k0.01% 0.01% ReducedShares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 119.0k, Q2 2026 1.0k -118.0k -118,000 -99.2%
97 NEOGENOMICS INC COM NEW NEO NEO 10,000 $145.9k0.01% 0.01% ReducedShares held: Q3 2025 0, Q4 2025 427.5k, Q1 2026 175.0k, Q2 2026 10.0k -165.0k -165,000 -94.3%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
VAXCYTE INC PCVX PCVX 385,472 $22.4m385.5k shares
ICON PLC ICLR ICLR 192,000 $21.2m192.0k shares
TRAVERE THERAPEUTICS INC TVTX TVTX 546,000 $16.2m546.0k shares
INHIBRX BIOSCIENCES INC INBX INBX 131,000 $8.8m131.0k shares
DEXCOM INC DXCM DXCM 140,000 $8.8m140.0k shares
IMMUNIC INC 4,500,000 $5.0m4.5m shares
ETON PHARMACEUTICALS INC ETON ETON 166,381 $4.1m166.4k shares
ARROWHEAD PHARMACEUTICALS IN ARWR ARWR 28,479 $1.8m28.5k shares
CYTOMX THERAPEUTICS INC CTMX CTMX 300,000 $1.4m300.0k shares
COGENT BIOSCIENCES INC COGT COGT 10,000 $384.9k10.0k shares
TYRA BIOSCIENCES INC TYRA TYRA 10,000 $383.0k10.0k shares
STAAR SURGICAL CO STAA STAA 20,000 $374.0k20.0k shares
ANAPTYSBIO INC ANAB ANAB 6,000 $332.8k6.0k shares
RAPPORT THERAPEUTICS INC RAPP RAPP 10,000 $312.9k10.0k shares
ZYMEWORKS INC ZYME ZYME 10,000 $250.4k10.0k shares
LB PHARMACEUTICALS INC LBRX LBRX 10,000 $246.6k10.0k shares
ORUKA THERAPEUTICS INC ORKA ORKA 5,000 $245.2k5.0k shares
JASPER THERAPEUTICS INC JSPR JSPR 276,312 $242.1k276.3k shares

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-06-11 PARABILIS MEDICINES INC 10% owner · See footnote PBLS Bought 500,000 $10.0m500.0k shares +329%